NLRP3 and COVID-19: In this study, we first found that the gene expression of NLRP3 and IL-1β was downregulated in the CD14+ and CD16+ monocytes from COVID-19 patients, while MARCH7 and IL-18 declined only in the CD16+ monocytes.